Regression of recurrent malignant gliomas with convection-enhanced delivery of topotecan
about
Promising approaches to circumvent the blood-brain barrier: progress, pitfalls and clinical prospects in brain cancer.Characterization of a novel anti-cancer compound for astrocytomasConvection-Enhanced Delivery of Carboplatin PLGA Nanoparticles for the Treatment of GlioblastomaNeurosurgical oncology: advances in operative technologies and adjuncts.The role of pH and ring-opening hydrolysis kinetics on liposomal release of topotecan.Convection-enhanced delivery of etoposide is effective against murine proneural glioblastoma.Vascular basement membranes as pathways for the passage of fluid into and out of the brain.Highly compacted pH-responsive DNA nanoparticles mediate transgene silencing in experimental gliomaTopoisomerase 1 inhibition reversibly impairs synaptic function.Minimizing the non-specific binding of nanoparticles to the brain enables active targeting of Fn14-positive glioblastoma cells.Neurocognitive functioning and quality of life in patients with recurrent malignant gliomas treated on a phase Ib trial evaluating topotecan by convection-enhanced deliveryInhibition of intracerebral glioblastoma growth by targeting the insulin-like growth factor 1 receptor involves different context-dependent mechanisms.Targeted therapy of glioblastoma stem-like cells and tumor non-stem cells using cetuximab-conjugated iron-oxide nanoparticlesOverlapping functions of ABC transporters in topotecan disposition as determined in gene knockout mouse models.Early Cerebral Blood Volume Changes Predict Progression After Convection-Enhanced Delivery of Topotecan for Recurrent Malignant Glioma.Understanding cytoskeleton regulators in glioblastoma multiforme for therapy designNovel therapeutic delivery approaches in development for pediatric gliomas.Convection enhanced delivery of panobinostat (LBH589)-loaded pluronic nano-micelles prolongs survival in the F98 rat glioma model.Convection-enhanced drug delivery to the brain: therapeutic potential and neuropathological considerations.Overcoming the blood-brain barrier in chemotherapy treatment of pediatric brain tumors.The role of cytotoxic chemotherapy in the management of progressive glioblastoma : a systematic review and evidence-based clinical practice guideline.Convection-enhanced delivery for the treatment of glioblastoma.Delivery of local therapeutics to the brain: working toward advancing treatment for malignant gliomas.Drug delivery approaches for the treatment of glioblastoma multiforme.Convection-enhanced delivery for glioblastoma: targeted delivery of antitumor therapeutics.Convection-Enhanced Delivery.Convection-enhanced Delivery of Therapeutics for Malignant Gliomas.Convection-enhanced delivery in glioblastoma: a review of preclinical and clinical studies.Blood-brain barrier, cytotoxic chemotherapies and glioblastoma.Interstitial chemotherapy for malignant glioma: Future prospects in the era of multimodal therapySurgical Considerations in the Optimal Management of Patients with Malignant Brain Tumors.Intrastriatal convection-enhanced delivery results in widespread perivascular distribution in a pre-clinical model.Convection-enhanced delivery for targeted delivery of antiglioma agents: the translational experience.Prolonged intracerebral convection-enhanced delivery of topotecan with a subcutaneously implantable infusion pumpConvection-enhanced drug delivery for gliomas.Convection-enhanced drug delivery: prospects for glioblastoma treatment.A novel implantable catheter system with transcutaneous port for intermittent convection-enhanced delivery of carboplatin for recurrent glioblastoma.Drug Delivery Nanosystems for the Localized Treatment of Glioblastoma Multiforme.A Critical Overview of Targeted Therapies for Glioblastoma
P2860
Q26778701-9DFFE051-AFD5-4B94-8960-7543788A80DDQ28543237-C0EA1472-DD02-4F93-BCC3-3431AADB88ACQ28546653-F45E21CB-5C62-40FB-9EE5-A60606E58C18Q30833619-DB04BADF-15D6-44F8-A0A9-9BFA6BD043FBQ33925422-1A694FA9-95DC-449B-838B-5F0FB1D5BC83Q34062017-1624F923-A2D0-4BDA-9B87-E2F20825523EQ34518100-88575007-191B-4065-9231-9D6FC3CB4D47Q34626825-692F770F-224C-4B42-9410-BE140F0032B1Q34661252-F252697F-75A9-4D18-AFC6-9B8A0C1C95AEQ34785621-5CF55C9F-4B1F-44DF-8347-E2669CAFC10EQ35206202-81F80A6A-931D-42AD-A2B8-AFEDEF941772Q35815279-85A9A0BF-EB78-446A-97D7-2CF4EF087DB2Q35832224-4429C1FE-A230-4265-B26B-5A3DDA1C1989Q37001278-D574A5E6-3079-4B66-9F15-35F247B7352BQ37042108-A736664F-893F-46A1-B196-F79A8C5CBE25Q37261902-75E339E8-911A-4447-B9AD-7BF4C46AC69CQ37551759-351F0E87-9248-492E-99BB-ADA1F26B9898Q37669168-7B432E80-2BC2-4CD6-9A01-288A21EB9497Q38128898-4FAB0EC6-5F59-4DB2-9AC3-F27784F11982Q38133407-54D99758-9131-49D1-9028-683404B36316Q38205133-F737E141-CCB8-41D9-8CFB-3F865294D8CFQ38368962-1768E72B-9BB4-4B52-AB74-9EB074E96B1CQ38411351-511AC91A-0660-4BDD-A230-2AD3D0B4A1FEQ38517047-18F7983C-7FE0-4DD9-86B8-12233A1331CEQ38535624-F4D9BE6B-B2DC-48E9-8A48-921FCBCFFC0DQ38744447-145D94E7-3698-42CB-9CB3-1FFF138BF479Q38782309-7F4EAE9F-CC99-459B-9EED-F13DA8109A60Q38795453-5281920D-8FB6-4924-86A3-1AFDA1379973Q38867048-EAC90E3C-169F-4575-B235-88DE02EE3B71Q39034877-EB492855-ECE5-42FB-A36C-934465FC1AF0Q39417263-6425D963-4534-4785-8E6F-960F16274E79Q40919532-4FFAE9F3-E34C-46EF-AC7C-8F13E43DC373Q41670963-E2F82A9D-4A44-485A-80B1-A20D5455C4D9Q42845568-0890716D-0D41-4ACC-9B84-92128183A78FQ43159976-D2DF8F7D-0886-4F18-A5F6-FE772C89EAD1Q48468678-AC2A314D-0B57-4E7C-A1AC-3CF7B614DCDDQ50425442-5F5B1CF5-7CC1-4892-B209-5FAB1E44B293Q54970083-202CEEC0-291D-4BD8-89B5-E052EB4C2D08Q58122179-91C5F197-BE1D-41E9-8497-247FCA2692E2
P2860
Regression of recurrent malignant gliomas with convection-enhanced delivery of topotecan
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Regression of recurrent malignant gliomas with convection-enhanced delivery of topotecan
@en
Regression of recurrent malignant gliomas with convection-enhanced delivery of topotecan.
@nl
type
label
Regression of recurrent malignant gliomas with convection-enhanced delivery of topotecan
@en
Regression of recurrent malignant gliomas with convection-enhanced delivery of topotecan.
@nl
prefLabel
Regression of recurrent malignant gliomas with convection-enhanced delivery of topotecan
@en
Regression of recurrent malignant gliomas with convection-enhanced delivery of topotecan.
@nl
P2093
P2860
P1433
P1476
Regression of recurrent malignant gliomas with convection-enhanced delivery of topotecan
@en
P2093
Benjamin C Kennedy
Candix L Yanes
Emilia Bagiella
Jeffrey N Bruce
Jonathan Yun
Krishna Surapaneni
Peter Canoll
Robert L DeLaPaz
Robert L Fine
P2860
P304
1272-9; discussion 1279-80
P356
10.1227/NEU.0B013E3182233E24
P407
P577
2011-12-01T00:00:00Z